Advances in Hematological Malignancies
Recent years have witnessed remarkable advancements in the area of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and therapy are transforming the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering hope for more successful treatment options.